This past year, researchers at Children's Hospital of Eastern Ontario announced the development of a new artificial intelligence-enabled search algorithm that can help identify patients who might have ...

A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...

AI in genomics offers transformative opportunities by enhancing drug discovery and personalized medicine through efficient genomic data analysis. Drivers include the surge in genomic data, the focus ...

Officially unveiled at the American Society of Human Genetics (ASHG) 2025 meeting held in Boston, Genomics has launched Mystra, an AI-enabled human genetics platform designed to accelerate drug target ...

In the rapidly evolving realm of genetics, the integration of artificial intelligence (AI) has ushered in new perspectives on therapeutic approaches and evolutionary processes. Traditional genetic ...

In the study The Shadow and the Self in Digital Twins in Healthcare as an AI Environment, published in AI & Society, researchers explore how digital twins may influence not only medical ...

The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. Biopharma ...

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely ...